Par Pharmaceuticals agrees $100m patent settlement

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Par Pharmaceuticals agrees $100m patent settlement

Managing IP Correspondent
September 23 2014

Par Pharmaceuticals has agreed to pay $100 million to a unit of Salix Pharmaceuticals and the University of Missouri to settle a lawsuit alleging it had infringed two patents related to the heartburn drug Zegerid

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

United StatesNewsPatentsNorth AmericaJurisdictions
managing-ip.png
Managing IP Correspondent
Contact
more from across site and SHARED ros bottom lb

More from across our site

Patents
11patrikhammareacutenpresidentofnokiatechnologies.jpg
Nokia eyes IP expansion amid ‘golden window’ for licensing
Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
Sanjana Mishra, November 21 2025
Patents
Group Standing.jpg
Gevers acquires Belgian attorney firm
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
November 21 2025
Patents
Dolby.jpg
This week on MIP: Dolby wins seminal PI | AI adoption in IP surges
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Sukanya Sarkar, November 21 2025
Managing IP Awards
wbl Americas 2026@4x.png
2026 Women in Business Law Americas Awards: submissions now open
Submit your nominations to this year's WIBL Americas Awards by January 23
Shailyn Tirado, November 20 2025
Managing IP Awards
Copy of EMEA awards 2024-Shortlist Announced-1200x627.png
Life Sciences Awards EMEA 2026: open for entries
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
James Wilson, November 20 2025
Patents
Reflective skyscraper business office buildings, bottom up view of big modern city urban landscape
Size for the sake of it? IP reaction to latest mega-merger
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Sukanya Sarkar, November 20 2025
Patents
merger-comp.jpg
Weekly take: Why Ashurst Perkins Coie merger should interest Australia’s IP market
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Sukanya Sarkar, November 20 2025
Copyright
AI create.jpeg
Thaler v Perlmutter: SCOTUS petition tests the ‘human-only rule’ for AI works
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Mitesh Patel, November 19 2025
Patents
Untitled design (1).png
Law firm founder warns of patent ‘over-optimism’
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
November 19 2025
Patents
Ericsson 2.jpg
UPC update: Ericsson deploys Taylor Wessing and Kather Augenstein for Transsion fight
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
November 19 2025
Gift this article